EFFICACY AND SAFETY OF COMPOUND-RESERPINE-TRIAMTERENE TABLETSIN TREATMENT TO NON-DIPPER HYPERTENSION IN ELDERLY

被引：0
|
作者：
Wang, Hongyi [1 ]
Chen, Yuanyuan [1 ]
Ma, Zhiyi [1 ]
Yang, Fan [1 ]
Sun, Ningling [1 ]
Wang, Hongyi [1 ]
机构：
[1] Peking Univ, Peoples Hosp, Heart Ctr, Beijing, Peoples R China
来源：
JOURNAL OF HYPERTENSION | 2018年 / 36卷
关键词：
compound-reserpine-triamterene tablets; elderly hypertension; blood pressure rhythm; chronotherapeutics;
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
A13979
引用
收藏
页码：E225 / E225
页数：1
相关论文
共 48 条
  • [31] Safety and efficacy of gefitinib treatment in elderly patients with non-small-cell lung cancer: Okayama Lung Cancer Study Group experience
    Hotta, K
    Ueoka, H
    Kiura, K
    Tabata, M
    Ogino, A
    Umemura, S
    Harita, S
    Gemba, K
    Yonei, T
    Bessho, A
    Maeda, T
    Tanimoto, M
    ACTA ONCOLOGICA, 2005, 44 (07) : 717 - 722
  • [32] Randomized, double-blind, placebo-controlled study of the safety and efficacy of vitamin B complex in the treatment of nocturnal leg cramps in elderly patients with hypertension
    Chan, P
    Huang, TY
    Chen, YJ
    Huang, WP
    Liu, YC
    JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 38 (12): : 1151 - 1154
  • [33] Tolerability and efficacy of retard form of Indapamide in the treatment of hypertension in elderly patients - (Results of multicenter open non-comparative trial in Russian program ARGUS)
    Kobalava, ZD
    Kotovskaya, YV
    Vereshchagina, GN
    Lukyanchikova, VF
    Nekrutenko, LA
    Nechaeva, GL
    Sklizkova, LA
    Slobodyanyuk, AL
    Filippenko, NG
    Shlyk, SV
    Maximenko, VV
    Moiseev, VS
    KARDIOLOGIYA, 2002, 42 (07) : 25 - 35
  • [34] Long term efficacy and safety of rivaroxaban plus cilostazol in the treatment of critical ischemia of the lower limbs in a frail, elderly patient with non valvular atrial fibrillation
    Antonio Trani
    Pietro Benedetto
    Ferdinando Di Leo
    Angela Baiano
    Andrea Esposito
    Danilo Menna
    Arianna Allegretti
    Pierluigi Antonino Cappiello
    Domenico Dell’Edera
    Journal of Pharmaceutical Health Care and Sciences, 6
  • [35] Long term efficacy and safety of rivaroxaban plus cilostazol in the treatment of critical ischemia of the lower limbs in a frail, elderly patient with non valvular atrial fibrillation
    Trani, Antonio
    Benedetto, Pietro
    Di Leo, Ferdinando
    Baiano, Angela
    Esposito, Andrea
    Menna, Danilo
    Allegretti, Arianna
    Cappiello, Pierluigi Antonino
    Dell'Edera, Domenico
    JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES, 2020, 6 (01)
  • [36] A systematic review and meta-analysis of efficacy and safety of compound glycyrrhizin combined with second-generation non-sedated antihistamine for the treatment of chronic urticaria
    Chen, Sijue
    Cao, Wei
    Xiao, Xianjun
    Wang, Lu
    Wan, Renhong
    Zou, Zihao
    Yang, Qian
    Li, Ying
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2024, 35 (01)
  • [37] EFFICACY AND SAFETY OF PEMETREXED AS SECOND-LINE TREATMENT IN ELDERLY PATIENTS (PTS) WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC): A RETROSPECTIVE ANALYSIS
    Passaro, A.
    Pochesci, A.
    Palleschi, M.
    Pellegrino, A.
    Fabbri, M. A.
    Urbano, F.
    Gentile, V.
    Manai, C.
    Pavese, I.
    Cortesi, E.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S70 - S70
  • [38] Treatment rationale and design of the PROLONG study: safety and efficacy of pembrolizumab as first-line therapy for elderly patients with non-small cell lung cancer
    Masuda, Takeshi
    Fujitaka, Kazunori
    Ishikawa, Nobuhisa
    Nakano, Kikuo
    Yamasaki, Masahiro
    Kitaguchi, Souichi
    Masuda, Ken
    Yamaguchi, Kakuhiro
    Sakamoto, Shinjiro
    Horimasu, Yasushi
    Kawase, Shigeo
    Miyamoto, Shintaro
    Nakashima, Taku
    Iwamoto, Hiroshi
    Shiota, Naoki
    Senoo, Tadashi
    Awaya, Yoshikazu
    Kondo, Tomohiro
    Yoshida, Takashi
    Hamada, Hironobu
    Murakami, Isao
    Hattori, Noboru
    JOURNAL OF THORACIC DISEASE, 2020, 12 (03) : 1079 - 1084
  • [39] Efficacy and safety of first-line nivolumab plus ipilimumab treatment in elderly patients (aged ≥ 75 years) with non-small cell lung cancer
    Satoshi Endo
    Hisao Imai
    Atsuto Mouri
    Kasumi Tsukamoto
    Kenji Masaki
    Kosuke Hashimoto
    Yu Miura
    Ayako Shiono
    Ou Yamaguchi
    Junichi Nakagawa
    Kyoichi Kaira
    Kunihiko Kobayashi
    Hiroshi Kagamu
    Journal of Cancer Research and Clinical Oncology, 151 (1)
  • [40] Safety and Efficacy of Nab-Paclitaxel for 2nd Line Treatment of Elderly Patients with Stage IV Non-Small Cell Lung Cancer
    Weiss, Jared
    Stinchcombe, Thomas
    Deal, Allison
    Villaruz, Liza
    Crane, Jeffrey
    West, Howard
    Lee, Carrie
    Stevenson, James
    Irvin, William
    Socinski, Mark
    Pennell, Nathan
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S912 - S913
12345